Physician profile
Scott C Clay
NPI 1003901117
$704.15
in general payments reported to CMS, 2019-2025
17 companies · $174 in 2025
The $174 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.34 · 2020: $11.98 · 2021: $146 · 2022: $137 · 2023: $34.43 · 2024: $133 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $341.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $105.68 | 2019-2022 | |
| Astellas Pharma US INC | $79.07 | 2021-2024 | Veozah, Myrbetriq |
| Boston Scientific Corporation | $67.28 | 2019-2024 | |
| Amgen INC. | $61.58 | 2021-2025 | Krystexxa, Evenity |
| Glaxosmithkline, LLC. | $59.26 | 2021-2025 | Arexvy, Shingrix |
| Abbott Laboratories | $42.22 | 2022 | |
| Nevro Corp. | $41.73 | 2021-2024 | Senza |
| Insulet Corporation | $35.69 | 2025 | Omnipod |
| Saluda Medical Americas, INC. | $34.72 | 2025 | Evoke |
| Astrazeneca Pharmaceuticals LP | $25.12 | 2022 | |
| Medtronic, INC. | $24.79 | 2022 | |
| Avanir Pharmaceuticals, INC. | $24.64 | 2020-2021 | |
| Spinal Simplicity, LLC | $24.33 | 2024 | Ha Minuteman G3-R |
| Biotronik Nro, INC. | $22.32 | 2025 | Prospera |
| Sunovion Pharmaceuticals INC. | $21.29 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $17.76 | 2023 | Wegovy |
| Sumitomo Pharma America, INC. | $16.67 | 2023 | Aptiom |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Clay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.